| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
Description: an insulin-low molecular weight amphiphilic polymer conjugate
Also Known As:| 1. | Still, J Gordon: 1 article (01/2002) |
| 2. | McAllister, R G: 1 article (01/2002) |
| 3. | Kosutic, Gordana: 1 article (01/2002) |
| 4. | Clement, Stephen: 1 article (01/2002) |
| 1. | Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/01/2004
- "Fourteen patients with type 1 diabetes mellitus were evaluated in an open-label, 2-center, dose-escalation, nonrandomized study of oral hexyl-insulin monoconjugate 2 (HIM2). "
01/01/2002 - "Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2." Order ALL the reference details at left... |
| 2. | Hyperglycemia
07/01/2005
- "We examined the extent to which priming the liver with a pulse of Humulin or the insulin analog hexyl-insulin monoconjugate 2 (HIM2) reduces postprandial hyperglycemia. "
Order ALL the reference details at left... |
| 1. | Insulin (Novolin)
|
| 2. | Glucose (Dextrose)
|
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
CureHunter research summary reports will vary in length from 25 to 250 pages.
Analytic charts allow you and your physicians to see at a glance your
medication options—including new, promising, off-label and experimental
all rated for clinical efficacy.
| Price: | $24.00
& Delivery via
PDF download
updates for 1 year |
| Price: | $490.00
access via web interface 1 year subscription |
| Price: | $45.00
access via "curehunter.com/m" 1 year subscription |